Grand River Aseptic Manufacturing
Grand River Aseptic Manufacturing (“GRAM”) is a leading sterile injectable drug manufacturer that provides biologic, small molecule, and vaccine capabilities for liquid and lyophilized vials, syringes, and cartridges. GRAM’s 300,000 sq. ft. of sophisticated GMP space in state-of-the-art facilities near downtown Grand Rapids, Michigan, supports pharmaceutical and biotech customers’ drug products with advanced equipment, innovative technology, and a breadth of experienced team members.
GRAM is known for its state-of-the-art technology, world-class facilities, customer-centric team, and regulatory compliance. GRAM manufactures customer drug products by taking the product’s formulation and transferring it into syringes, cartridges, or vials, then packages based on client needs. Current industry trends focus on drug delivery systems, such as on-body devices, to enhance patient care. GRAM stays at the forefront by providing capabilities that support advances in healthcare to meet a range of fill-and-finish needs from clinical trials through commercialization.
Our History
2010
- Company founded to support the life sciences industry’s growing need for quality sterile injectable manufacturing services.
2013
- 1st commercial product FDA approved.
2017
- Arlington Capital Partners becomes the new majority owner, offering capital for expanding capacity and continuing to invest in best-in-class technology.
2018
- Large-scale filling expansion began to increase capacity and serve more pharma and biotech clients.
2020
- Large-scale filling expansion complete.
- Selected by the U.S. Government for Operation Warp Speed.
- Partnered with Johnson & Johnson to manufacture COVID-19 vaccine.
2021
- FOYA Award Winner for Special Recognition for Operational Agility: COVID-19 Impact.
- Grand opening of new 200,000+ sq. ft. inspection, finishing, and warehouse center.
2022
- Phase 2 filling expansion complete, reaching over 50 million units per year with space to serve a greater variety of pharma and biotech customers.
- Selected by the U.S. Government for domestic Medical Countermeasures Capacity partnership for future pandemic preparedness.
- Partnered with Bavarian Nordic to manufacture JYNNEOS vaccine.
2023
- 7-time Inc 5000 Fastest-Growing Private Companies in America.
- 5- time West Michigan’s Best and Brightest Companies to Work For®.
- 2023 Best and Brightest Companies to Work For® in the Nation.
- Contributed over 840 hours of paid volunteer time off serving local charities through GRAM’s GoBeyond program.
2024
- 90,000 sq. ft. expansion of inspection, finishing, and warehouse center complete.
- Introduced Wellness Time Off to GRAM’s 440+ employees.
- Employ a diverse team of talent ranging from high school diplomas to advanced postgraduate degrees.
- Occupy 6 facilities in Grand Rapids.
GRAM’s authenticity and transparency with our partners and component manufacturers allow us to serve intentionally and continue our growth. We are proud to have products that positively impact the health of people around the world. With over 100 million units of capacity, GRAM is ready to support pharma and biotech customers further.
Leadership
Our leadership team comprises seasoned pharmaceutical, biotechnology, and life science experts. Grand River Aseptic Manufacturing employees have direct access to our executives, simplifying the decision-making rate.
Meet the executive team
Infusing Core Values In Daily Operations
